<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Endocrinol (Oxf)</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin. Endocrinol. (Oxf)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1365-2265</journal-id>
<journal-id journal-id-type="publisher-id">CEN</journal-id>
<journal-title-group>
<journal-title>Clinical Endocrinology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0300-0664</issn>
<issn pub-type="epub">1365-2265</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30238501</article-id>
<article-id pub-id-type="pmc">6283248</article-id>
<article-id pub-id-type="doi">10.1111/cen.13841</article-id>
<article-id pub-id-type="publisher-id">CEN13841</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>ORIGINAL ARTICLES</subject>
<subj-group subj-group-type="heading">
<subject>Paediatric Endocrinology</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Comprehensive screening shows that mutations in the known syndromic genes are rare in infants presenting with hyperinsulinaemic hypoglycaemia</article-title>
<alt-title alt-title-type="left-running-head">LAVER et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="cen13841-cr-0001">
<name>
<surname>Laver</surname>
<given-names>Thomas W.</given-names>
</name>
<xref ref-type="aff" rid="cen13841-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cen13841-cr-0002">
<name>
<surname>Wakeling</surname>
<given-names>Matthew N.</given-names>
</name>
<xref ref-type="aff" rid="cen13841-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cen13841-cr-0003">
<name>
<surname>Hua</surname>
<given-names>Janet Hong Yeow</given-names>
</name>
<xref ref-type="aff" rid="cen13841-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cen13841-cr-0004">
<name>
<surname>Houghton</surname>
<given-names>Jayne A. L.</given-names>
</name>
<xref ref-type="aff" rid="cen13841-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cen13841-cr-0005">
<name>
<surname>Hussain</surname>
<given-names>Khalid</given-names>
</name>
<xref ref-type="aff" rid="cen13841-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cen13841-cr-0006">
<name>
<surname>Ellard</surname>
<given-names>Sian</given-names>
</name>
<xref ref-type="aff" rid="cen13841-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="cen13841-cr-0007">
<name>
<surname>Flanagan</surname>
<given-names>Sarah E.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8670-6340</contrib-id>
<address>
<email>S.Flanagan@exeter.ac.uk</email>
</address>
<xref ref-type="aff" rid="cen13841-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="cen13841-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Institute of Biomedical and Clinical Science</named-content>
<institution>University of Exeter Medical School</institution>
<named-content content-type="city">Exeter</named-content>
<country country="GB">UK</country>
</aff>
<aff id="cen13841-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Paediatric Department</named-content>
<institution>Hospital Putrajaya</institution>
<named-content content-type="city">Putrajaya</named-content>
<country country="MY">Malaysia</country>
</aff>
<aff id="cen13841-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Molecular Genetics</named-content>
<institution>Royal Devon and Exeter NHS Foundation Trust</institution>
<named-content content-type="city">Exeter</named-content>
<country country="GB">UK</country>
</aff>
<aff id="cen13841-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Pediatric Medicine</named-content>
<named-content content-type="organisation-division">Division of Endocrinology</named-content>
<institution>Sidra Medicine</institution>
<named-content content-type="city">Doha</named-content>
<country country="QA">Qatar</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Sarah E. Flanagan, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.<break></break>
Email: <email>S.Flanagan@exeter.ac.uk</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year>
</pub-date>
<volume>89</volume>
<issue>5</issue>
<issue-id pub-id-type="doi">10.1111/cen.2018.89.issue-5</issue-id>
<fpage>621</fpage>
<lpage>627</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2018 John Wiley & Sons Ltd <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Clinical Endocrinology</italic> Published by John Wiley &amp; Sons Ltd.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CEN-89-621.pdf" xlink:type="simple"></self-uri>
<abstract id="cen13841-abs-0001">
<title>Summary</title>
<sec id="cen13841-sec-0001">
<title>Objective</title>
<p>Hyperinsulinaemic hypoglycaemia (<styled-content style="fixed-case">HH</styled-content>) can occur in isolation or more rarely feature as part of a syndrome. Screening for mutations in the “syndromic” <styled-content style="fixed-case">HH</styled-content> genes is guided by phenotype with genetic testing used to confirm the clinical diagnosis. As <styled-content style="fixed-case">HH</styled-content> can be the presenting feature of a syndrome, it is possible that mutations will be missed as these genes are not routinely screened in all newly diagnosed individuals. We investigated the frequency of pathogenic variants in syndromic genes in infants with <styled-content style="fixed-case">HH</styled-content> who had not been clinically diagnosed with a syndromic disorder at referral for genetic testing.</p>
</sec>
<sec id="cen13841-sec-0002">
<title>Design</title>
<p>We used genome sequencing data to assess the prevalence of mutations in syndromic <styled-content style="fixed-case">HH</styled-content> genes in an international cohort of patients with <styled-content style="fixed-case">HH</styled-content> of unknown genetic cause.</p>
</sec>
<sec id="cen13841-sec-0003">
<title>Patients</title>
<p>We undertook genome sequencing in 82 infants with <styled-content style="fixed-case">HH</styled-content> without a clinical diagnosis of a known syndrome at referral for genetic testing.</p>
</sec>
<sec id="cen13841-sec-0004">
<title>Measurements</title>
<p>Within this cohort, we searched for the genetic aetiologies causing 20 different syndromes where <styled-content style="fixed-case">HH</styled-content> had been reported as a feature.</p>
</sec>
<sec id="cen13841-sec-0005">
<title>Results</title>
<p>We identified a pathogenic <italic><styled-content style="fixed-case">KMT</styled-content>2D</italic> variant in a patient with <styled-content style="fixed-case">HH</styled-content> diagnosed at birth, confirming a genetic diagnosis of Kabuki syndrome. Clinical data received following the identification of the mutation highlighted additional features consistent with the genetic diagnosis. Pathogenic variants were not identified in the remainder of the cohort.</p>
</sec>
<sec id="cen13841-sec-0006">
<title>Conclusions</title>
<p>Pathogenic variants in the syndromic <styled-content style="fixed-case">HH</styled-content> genes are rare; thus, routine testing of these genes by molecular genetics laboratories is unlikely to be justified in patients without syndromic phenotypes.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="cen13841-kwd-0001">genetic screening</kwd>
<kwd id="cen13841-kwd-0002">hyperinsulinaemia hypoglycaemia of infancy</kwd>
<kwd id="cen13841-kwd-0003">medical genetics</kwd>
<kwd id="cen13841-kwd-0004">molecular diagnostics</kwd>
<kwd id="cen13841-kwd-0005">mutation</kwd>
<kwd id="cen13841-kwd-0006">neonatal hyperinsulinism</kwd>
<kwd id="cen13841-kwd-0007">syndrome</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Wellcome Trust</funding-source>
<award-id>105636/Z/14/Z</award-id>
<award-id>WT098395/Z/12/Z</award-id>
</award-group>
<award-group>
<funding-source>Royal Society</funding-source>
<award-id>105636/Z/14/Z</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<page-count count="7"></page-count>
<word-count count="4263"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>cen13841</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>November 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.3 mode:remove_FC converted:06.12.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="cen13841-cit-1001" publication-type="journal">
<string-name>
<surname>Laver</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Wakeling</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Hua</surname>
<given-names>JHY</given-names>
</string-name>, et al. <article-title>Comprehensive screening shows that mutations in the known syndromic genes are rare in infants presenting with hyperinsulinaemic hypoglycaemia</article-title>. <source xml:lang="en"/>Clin Endocrinol (Oxf). <year>2018</year>;<volume>89</volume>:<fpage>621</fpage>–<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1111/cen.13841</pub-id>
<pub-id pub-id-type="pmid">30238501</pub-id></mixed-citation>
</p>
</notes>
</front>
<body>
<sec id="cen13841-sec-0007">
<label>1</label>
<title>INTRODUCTION</title>
<p>Congenital hyperinsulinaemic hypoglycaemia (HH) is a disorder where episodes of hypoglycaemia are caused by unregulated insulin secretion despite low blood glucose levels. Prompt treatment is crucial in order to avoid serious lifelong complications such as seizures and permanent brain injury.<xref ref-type="ref" rid="cen13841-bib-0001">1</xref> Genetic testing is important for the clinical management of this condition as identifying the underlying genetic aetiology will inform on the pancreatic histology which, for patients who are unresponsive to medical treatment, will help to determine whether a lesionectomy or a near‐total pancreatectomy is required.<xref ref-type="ref" rid="cen13841-bib-0002">2</xref>
</p>
<p>HH is most commonly the result of a monogenic aetiology with mutations in at least eight genes reported to cause isolated disease.<xref ref-type="ref" rid="cen13841-bib-0003">3</xref> Routine screening of these genes using a combination of rapid Sanger sequencing and targeted next‐generation sequencing identifies a mutation in approximately 40%‐50% of cases with persistent HH.<xref ref-type="ref" rid="cen13841-bib-0003">3</xref> This suggests that further genetic aetiologies remain to be discovered.</p>
<p>HH has also been reported as a feature in at least 20 different rare genetic syndromes.<xref ref-type="ref" rid="cen13841-bib-0001">1</xref> The most common is Beckwith‐Wiedemann syndrome where HH occurs in approximately 50% of cases.<xref ref-type="ref" rid="cen13841-bib-0004">4</xref> More rarely, HH has been described in individuals with other overgrowth disorders including Sotos syndrome<xref ref-type="ref" rid="cen13841-bib-0005">5</xref> and growth delay syndromes such as Kabuki.<xref ref-type="ref" rid="cen13841-bib-0006">6</xref> HH has also been reported in some cases with congenital disorders of glycosylation and chromosome abnormalities such as Turner syndrome and Patau syndrome.<xref ref-type="ref" rid="cen13841-bib-0007">7</xref>, <xref ref-type="ref" rid="cen13841-bib-0008">8</xref>, <xref ref-type="ref" rid="cen13841-bib-0009">9</xref>, <xref ref-type="ref" rid="cen13841-bib-0010">10</xref> For patients with syndromic HH, an early genetic diagnosis is important as this will guide medical management and provide information on prognosis and recurrence risk.</p>
<p>Screening of the syndromic genes is not routinely performed as part of the genetic testing strategy for individuals with HH. The targeted analysis of a gene is usually only performed when there is a clinical suspicion of a specific syndrome in an individual and therefore acts to confirm the clinical diagnosis.<xref ref-type="ref" rid="cen13841-bib-0011">11</xref> Consequently, the prevalence of mutations in these genes in HH is not known. As many patients are referred for genetic testing at diagnosis of HH, it is possible that some individuals with a mutation in a syndromic gene will not have developed additional extra‐pancreatic features at the time of referral for genetic testing. These patients may therefore not receive the most appropriate genetic testing.</p>
<p>In order to assess the frequency of mutations in the known syndromic genes in individuals with HH of unknown genetic cause, we performed a comprehensive analysis of genome sequencing data from 82 affected infants. Screening patients for mutations in the “syndromic” HH genes irrespective of clinical features has the advantage that a genetic diagnosis can precede development of clinical features and guide clinical management, rather than being confirmatory.</p>
</sec>
<sec id="cen13841-sec-0008">
<label>2</label>
<title>MATERIALS AND METHODS</title>
<sec id="cen13841-sec-0009">
<label>2.1</label>
<title>Patient details</title>
<p>82 infants with HH diagnosed within the first 12 months of life were referred for genetic testing to the Molecular Genetics Laboratory at the Royal Devon and Exeter NHS Foundation Trust. All patients in the cohort had received a biochemical diagnosis of HH in their local centre. All patients had a blood glucose of &lt;2.8 mmol/L (median 1.9 mmol/L) with a concomitant insulin of &gt;15 pmol/L (median 96 pmol/L) and/or a c‐peptide of &gt;300 pmol/L (see Table <xref ref-type="table" rid="cen13841-tbl-0001">1</xref>). In all cases, the HH had persisted for greater than 6 months or had required pancreatic resection following a poor response to treatment. In 15 patients, extra‐pancreatic features were present at the time of referral for genetic testing. None of these patients had received a clinical diagnosis consistent with a known syndromic form of HH at the time of study. Mutations in the <italic>ABCC8</italic>,<italic> KCNJ11</italic>,<italic> HADH</italic>,<italic> HNF4A</italic>,<italic> HNF1A</italic>,<italic> GLUD1</italic>,<italic> GCK,</italic> and <italic>SLC16A1</italic> genes had been excluded in all patients using targeted next‐generation sequencing.<xref ref-type="ref" rid="cen13841-bib-0011">11</xref> The coding regions of the HH candidate genes, <italic>UCP2</italic> and <italic>HK1</italic>, were also screened but no likely pathogenic variants were identified in the cohort.<xref ref-type="ref" rid="cen13841-bib-0012">12</xref>, <xref ref-type="ref" rid="cen13841-bib-0013">13</xref>, <xref ref-type="ref" rid="cen13841-bib-0014">14</xref>
</p>
<table-wrap id="cen13841-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Clinical characteristics of the 82 patients included in this study. All patients had received a clinical diagnosis of HH from their referring clinician, with biochemical testing undertaken in their local laboratories. When applicable, median values are given with the range</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Reported consanguineous</td>
<td align="left" colspan="1" rowspan="1">18%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sex (% male)</td>
<td align="left" colspan="1" rowspan="1">48%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Birth weight kg (gestation)</td>
<td align="left" colspan="1" rowspan="1">3.5 (39 wk) [2.0‐5.2 (35‐41 wk)]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Current age (y)</td>
<td align="left" colspan="1" rowspan="1">6.5 [1‐35]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age at diagnosis of HH (wk)</td>
<td align="left" colspan="1" rowspan="1">4 [0‐48]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Blood glucose at diagnosis (mmol/L)</td>
<td align="left" colspan="1" rowspan="1">1.9 [&lt;1‐2.8]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Insulin at time of hypoglycaemia (pmol/L)</td>
<td align="left" colspan="1" rowspan="1">96 [15‐365]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C‐peptide at diagnosis (pmol/L)</td>
<td align="left" colspan="1" rowspan="1">775 [150‐2400]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Extra‐pancreatic features</td>
<td align="left" colspan="1" rowspan="1">n = 15</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>The study was approved by the North Wales Research Ethics Committee. Consent was obtained from each patient after full explanation of the purpose and nature of all procedures used.</p>
</sec>
<sec id="cen13841-sec-0010">
<label>2.2</label>
<title>Gene panel and variant calling</title>
<p>We utilized the Phenomizer browser to identify disease entries annotated for hyperinsulinaemic hypoglycaemia (HPO id: 0000825).<xref ref-type="ref" rid="cen13841-bib-0015">15</xref> A survey of the literature was also undertaken to identify further genes in which mutations have been reported to cause HH as part of a syndrome.</p>
<p>Whole‐genome sequencing was performed on DNA extracted from peripheral blood leucocytes of the 82 probands. All samples were sequenced on an Illumina HiSeq 2500 or Illumina X10 (Illumina, San Diego, California, USA) with a mean read depth of 33.25 (SD 4.25). The sequencing data were analysed using an approach based on the GATK best practice guidelines.<xref ref-type="ref" rid="cen13841-bib-0016">16</xref> This involved aligning the reads to the hg19/GRCh37 human reference genome with BWA mem, applying Picard for duplicates removal, and GATK IndelRealigner for local realignment and running the base quality score realignment. GATK haplotypeCaller was used to identify variants, which were annotated using Alamut Batch version 1.8 (Interactive Biosoftware, Rouen, France), and variants which failed the QD2 VCF filter or had &lt;5 reads supporting the variant allele were excluded. Variants that passed filtering were confirmed by Sanger sequencing and tested in the parents (details of primer sequences are available on request). CNVs were called by SavvyCNV, which uses read depth to judge copy number states.<xref ref-type="ref" rid="cen13841-bib-0017">17</xref> Uniparental isodisomy was detected using a hidden Markov model to detect regions with a significant number of variants that were opposite homozygous between the proband and one parent.</p>
</sec>
</sec>
<sec id="cen13841-sec-0011">
<label>3</label>
<title>RESULTS</title>
<p>We identified 20 genetic syndromes in which HH has been reported as a feature (Table <xref ref-type="table" rid="cen13841-tbl-0002">2</xref>). In 82 patients, we screened the coding regions and intron/exon boundaries of the 18 genes associated with these syndromes. We also searched for copy number variations (CNVs) and evidence of uniparental isodisomy at genomic regions associated with Beckwith‐Wiedemann, Patau and Turner syndromes.</p>
<table-wrap id="cen13841-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Syndromes in which hyperinsulinaemic hypoglycaemia (HH) has been reported as a feature. The 18 genes in which mutations have been reported to cause syndromic HH plus the three genomic regions known to be affected by copy number variants (CNVs) or uniparental isodisomy (UPD) are provided</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Syndrome</th>
<th align="left" colspan="1" rowspan="1" valign="top">OMIM Gene(s)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Inheritance</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
<th align="left" colspan="1" rowspan="1" valign="top">HH clinical features<xref ref-type="fn" rid="cen13841-note-0001">[Link]</xref>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Adenosine kinase deficiency</td>
<td align="left" colspan="1" rowspan="1">
<italic>ADK</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Staufner et al<xref ref-type="ref" rid="cen13841-bib-0023">23</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset. Recurrent. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital disorders of glycosylation (type 1d)</td>
<td align="left" colspan="1" rowspan="1">
<italic>ALG3</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Sun et al<xref ref-type="ref" rid="cen13841-bib-0007">7</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Timothy</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1C</italic>
</td>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="left" colspan="1" rowspan="1">Splawski et al<xref ref-type="ref" rid="cen13841-bib-0024">24</xref>
</td>
<td align="left" colspan="1" rowspan="1">Childhood onset. Recurrent</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1D</italic>
</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1D</italic>
</td>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="left" colspan="1" rowspan="1">Flanagan et al<xref ref-type="ref" rid="cen13841-bib-0025">25</xref>
</td>
<td align="left" colspan="1" rowspan="1">Onset from birth. Persistent and transient reported. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Beckwith‐Wiedemann</td>
<td align="left" colspan="1" rowspan="1">
<italic>CDKN1C</italic>, UPD or CNVs at 11p15</td>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="left" colspan="1" rowspan="1">Munns and Batch<xref ref-type="ref" rid="cen13841-bib-0004">4</xref>
</td>
<td align="left" colspan="1" rowspan="1">Onset in neonatal period. Transient. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Perlman</td>
<td align="left" colspan="1" rowspan="1">
<italic>DIS3L2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Henneveld et al<xref ref-type="ref" rid="cen13841-bib-0026">26</xref>
</td>
<td align="left" colspan="1" rowspan="1">Onset from birth</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tyrosinaemia type I</td>
<td align="left" colspan="1" rowspan="1">
<italic>FAH</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Baumann et al<xref ref-type="ref" rid="cen13841-bib-0027">27</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset. Transient. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Simpson‐Golabi‐Behmel</td>
<td align="left" colspan="1" rowspan="1">
<italic>GPC3</italic>
</td>
<td align="left" colspan="1" rowspan="1">X‐linked recessive</td>
<td align="left" colspan="1" rowspan="1">Terespolsky et al<xref ref-type="ref" rid="cen13841-bib-0028">28</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Costello</td>
<td align="left" colspan="1" rowspan="1">
<italic>HRAS</italic>
</td>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="left" colspan="1" rowspan="1">Sheffield et al<xref ref-type="ref" rid="cen13841-bib-0029">29</xref>
</td>
<td align="left" colspan="1" rowspan="1">Onset from birth. Transient</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Insulin resistance syndrome (leprechaunism)</td>
<td align="left" colspan="1" rowspan="1">
<italic>INSR</italic>
</td>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="left" colspan="1" rowspan="1">Hojlund et al<xref ref-type="ref" rid="cen13841-bib-0030">30</xref>
</td>
<td align="left" colspan="1" rowspan="1">Onset 3 to 30 years of age. Postprandial HH. Octreotide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Kabuki</td>
<td align="left" colspan="1" rowspan="1">
<italic>KMT2D, KDM6A</italic>
</td>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="left" colspan="1" rowspan="1">Gole et al<xref ref-type="ref" rid="cen13841-bib-0006">6</xref>
</td>
<td align="left" colspan="1" rowspan="1">Onset from birth. Persistent. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital disorder of glycosylation (type 1b)</td>
<td align="left" colspan="1" rowspan="1">
<italic>MPI</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Deeb and Amoodi<xref ref-type="ref" rid="cen13841-bib-0031">31</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset. Persistent. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sotos</td>
<td align="left" colspan="1" rowspan="1">
<italic>NSD1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="left" colspan="1" rowspan="1">Baujat et al<xref ref-type="ref" rid="cen13841-bib-0005">5</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset. Persistent. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital disorder of glycosylation (type 1t)</td>
<td align="left" colspan="1" rowspan="1">
<italic>PGM1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Tegtmeyer et al<xref ref-type="ref" rid="cen13841-bib-0008">8</xref>
</td>
<td align="left" colspan="1" rowspan="1">Childhood onset. Recurrent</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Central hypoventilation syndrome</td>
<td align="left" colspan="1" rowspan="1">
<italic>PHOX2B </italic>
</td>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="left" colspan="1" rowspan="1">Hennewig et al<xref ref-type="ref" rid="cen13841-bib-0032">32</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset. Recurrent. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital disorder of glycosylation (type 1a)</td>
<td align="left" colspan="1" rowspan="1">
<italic>PMM2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Bohles et al<xref ref-type="ref" rid="cen13841-bib-0033">33</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset. Persistent. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Polycystic Kidney Disease with HH</td>
<td align="left" colspan="1" rowspan="1">
<italic>PMM2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Cabezas et al<xref ref-type="ref" rid="cen13841-bib-0009">9</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal/childhood onset. Persistent. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TRMT10A</td>
<td align="left" colspan="1" rowspan="1">
<italic>TRMT10A</italic>
</td>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="left" colspan="1" rowspan="1">Gillis et al<xref ref-type="ref" rid="cen13841-bib-0034">34</xref>
</td>
<td align="left" colspan="1" rowspan="1">Childhood onset. Persistent. Diazoxide responsive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Patau syndrome</td>
<td align="left" colspan="1" rowspan="1">Trisomy 13</td>
<td align="left" colspan="1" rowspan="1">
<italic> </italic>De novo</td>
<td align="left" colspan="1" rowspan="1">Smith and Giacoia<xref ref-type="ref" rid="cen13841-bib-0035">35</xref>
</td>
<td align="left" colspan="1" rowspan="1">Onset from birth. Transient</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Turner</td>
<td align="left" colspan="1" rowspan="1">X Chromosome deletions</td>
<td align="left" colspan="1" rowspan="1"> <italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Alkhayyat et al<xref ref-type="ref" rid="cen13841-bib-0010">10</xref>
</td>
<td align="left" colspan="1" rowspan="1">Neonatal onset. Persistent. Diazoxide responsive</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="cen13841-note-0001">
<p>Features of HH as reported in cases from the published literature.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>We identified 70 nonsynonymous (nonsense, frameshift, splice site, missense) variants in the 18 genes. As the incidence of HH in outbred populations is estimated to be between 1 in 27 000 and 1 in 50 000,<xref ref-type="ref" rid="cen13841-bib-0018">18</xref> we excluded all variants in dominant genes that were present in gnomAD controls<xref ref-type="ref" rid="cen13841-bib-0019">19</xref> at a frequency greater than 1 in 27 000. In addition, we excluded variants that did not fit the known inheritance pattern of the syndrome: excluding single heterozygous variants in recessive genes and variants inherited from an unaffected parent in dominant genes. This left one <italic>de novo</italic> variant in the <italic>KMT2D</italic> gene where dominantly inherited loss‐of‐function mutations are reported to cause Kabuki syndrome.<xref ref-type="ref" rid="cen13841-bib-0006">6</xref>
</p>
<p>CNVs were not detected at any of the regions analysed, and analysis of single polymorphisms excluded uniparental isodisomy at the Beckwith‐Wiedemann syndrome locus at chromosome 11p15.5. All patients had normal dosage of chromosome 13, and all females had a 46XX karyotype, which excluded Patau and Turner syndromes, respectively.</p>
<p>The heterozygous frameshift variant in the <italic>KMT2D</italic> gene p.(Lys5244Serfs*13), (c.15731_15732del) and (NM_003482.3) (Figure <xref ref-type="fig" rid="cen13841-fig-0001">1</xref>) had arisen <italic>de novo</italic> in the proband and was classified as “pathogenic” according to the American College of Medical Genetic guidelines.<xref ref-type="ref" rid="cen13841-bib-0020">20</xref> The female patient was of Sarawakian ethnicity born in Malaysia to nonconsanguineous parents at 38 weeks of gestation with a birthweight of 3.36 kg. During the pregnancy, her mother was diagnosed with gestational diabetes that was controlled by diet and the pregnancy was complicated by polyhydramnios. Hypoglycaemia was diagnosed in the proband at birth (2.0 mmol/L), which required intermittent intravenous dextrose for recurrent symptomatic hypoglycaemia until day 30 of life. Diazoxide treatment (5 mg/kg/d) and hydrochlorothiazide treatment (1.5 mg/kg/twice daily) were started at 30 days, which resulted in euglycaemia. Hyperinsulinism as the cause of hypoglycaemia was confirmed biochemically. The patient required continuous diazoxide treatment and a nasogastric tube for feeding. At the age of 6 months, the patient was referred for genetic testing of the genes causing isolated HH. At referral, the only extra‐pancreatic feature reported to the genetics laboratory was gastro‐oesophageal reflux. At follow‐up subsequent to the genetic diagnosis, clinical features consistent with a diagnosis of Kabuki syndrome were reported. At the age of 5 months, her weight was 6.06 kg (10th‐50th centile), height was 60 cm (&lt;10th centile), and head circumference was 38.5 cm (&lt;10th centile). She had soft facial dysmorphism, hypotonia and laryngomalacia with inspiratory stridor. Her gross and fine motor development was delayed. She also had a resolved small muscular ventricular septal defect and congenital small right kidney with normal left kidney. She had recurrent pneumonia and died before reaching 1 year of age.</p>
<fig fig-type="Figure" id="cen13841-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>
<italic><styled-content style="fixed-case">KMT</styled-content>2D</italic> variant hg19/<styled-content style="fixed-case">GRC</styled-content>h37:g.49420017_49420018del/<styled-content style="fixed-case">NM</styled-content>_003482:c.15731_15732del/p.Lys5244Serfs*13. Visualized in integrative genomics viewer (<styled-content style="fixed-case">IGV</styled-content>). It shows the sequencing reads. (horizontal grey bars) mapping to exon 48 of the <italic><styled-content style="fixed-case">KMT</styled-content>2D</italic> gene located at genomic position 49,420,017 on chromosome 12. The reference nucleotide sequence and the amino acid translation are provided under the sequencing reads. The heterozygous deletion of <styled-content style="fixed-case">TT</styled-content> is illustrated by ‐2‐ and is present in 15 of the 25 sequencing reads present at this position. The deletion causes a frameshift.</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="CEN-89-621-g001"></graphic>
</fig>
</sec>
<sec id="cen13841-sec-0012">
<label>4</label>
<title>DISCUSSION</title>
<p>We screened for genetic aetiologies where HH has been reported to feature as part of a complex syndrome in 82 patients with HH of unknown cause. We identified one patient with a pathogenic variant in <italic>KMT2D</italic> that confirmed a diagnosis of Kabuki syndrome.<xref ref-type="ref" rid="cen13841-bib-0006">6</xref> At referral, the patient was reported to the genetics laboratory as having persistent HH and gastro‐oesophageal reflux. At follow‐up subsequent to the genetic diagnosis, clinical features consistent with a diagnosis of Kabuki syndrome were reported. These included a structural heart defect with growth and developmental delay. It is possible that if the patient had been referred to a specialist clinical geneticist, a clinical diagnosis of Kabuki syndrome would have been made. As the patient died before the age of 1 year, it is not possible to ascertain whether they would have developed further features of this syndrome. Recently, Yap et al<xref ref-type="ref" rid="cen13841-bib-0021">21</xref> described a cohort of 10 patients with pathogenic variants in <italic>KDM6A</italic> who presented with HH before receiving a diagnosis of Kabuki syndrome later in life suggesting that HH may be a more common presenting feature than previously recognized. Their screening of an additional 100 isolated HH patients identified one further patient (who was retrospectively recognized to have the classic syndromic phenotype), which is a similar frequency to our study.</p>
<p>Mutations in the “syndromic” HH genes were not identified in the majority of our cohort (81/82 patients). Our patients were selected due to the presence of persistent HH rather than a syndromic phenotype. Our low pickup rate suggests that mutations in these genes are rare in patients presenting with isolated HH. It is likely that for the majority of cases with syndromic disease, additional features are evident from birth allowing for a clinical diagnosis followed by confirmatory genetic testing. This would consequently reduce the prevalence of cases within our cohort as the majority of patients are referred for routine screening of the 8 known isolated HH genes. Heterozygous variants in genes that cause a dominant disease were excluded if they were inherited from an unaffected parent; however, it is possible that these could be pathogenic but displaying incomplete penetrance in the parents. We can also not rule out the possibility that some patients have mutations in other genes known to cause multisystem disease which was not screened in this study as HH has not been recognized as a common feature. Furthermore, it is possible that some patients with Beckwith‐Wiedemann syndrome have a methylation defect in the absence of a structural abnormality that was not detected by our analysis.</p>
<p>The finding that the patient with Kabuki syndrome had HH as the presenting feature highlights the potential benefit of screening for the syndromic genes in individuals newly diagnosed with HH. Identifying the underlying genetic aetiology is important for these patients as it will inform on prognosis which will allow for better clinical management. A genetic diagnosis also provides important information on recurrence risk.</p>
<p>We found that mutations causing these 20 syndromes are rare. The recent adoption of targeted next‐generation sequencing by molecular genetics laboratories makes screening of multiple genes for conditions such as HH feasible. An early and accurate genetic diagnosis of a syndrome has benefits for patient care. However, there are some disadvantages of this approach in terms of the difficulties with variant interpretation in the absence of additional clinical features and the extra time required for the analysis of the genetic data. Thus, routine testing of this panel of genes may not be justified for patients without syndromic features as we have shown that mutations in these genes are rare in such a cohort. It is anticipated that variant interpretation will become easier through data sharing initiatives such as ClinVar,<xref ref-type="ref" rid="cen13841-bib-0022">22</xref> and as the number of publically available control data sets increase, more variants can be excluded by frequency.<xref ref-type="ref" rid="cen13841-bib-0019">19</xref> This may make testing of these genes in all patients with HH more feasible in future.</p>
<p>Screening large cohorts for mutations in these genes will provide further information on the prevalence of mutations in HH, which will help to guide future genetic screening strategies for this condition and may also identify individuals with “nonclassical” features, which would expand the phenotype associated with these syndromes.</p>
<p>In conclusion, while the clinical impact of finding a mutation in a syndromic gene is high as it can inform clinical management, mutations in the syndromic HH genes are rare in individuals referred for routine testing for HH. Given the time‐consuming nature of a comprehensive screen, routine testing of these genes by molecular genetics laboratories is unlikely to be justified in patients without syndromic phenotypes.</p>
</sec>
<sec id="cen13841-sec-0014">
<title>CONFLICT OF INTEREST</title>
<p>The authors have no conflict of interests to declare.</p>
</sec>
<sec id="cen13841-sec-0015">
<title>AUTHOR CONTRIBUTIONS</title>
<p>TWL and SEF designed the study. JHYH and KH recruited patients and performed clinical phenotyping. TWL and MNW analysed the sequencing data. JALH, SE and SEF performed variant interpretation. TWL and SEF wrote the manuscript. All authors reviewed and approved the manuscript.</p>
</sec>
</body>
<back>
<ack id="cen13841-sec-0013">
<title>ACKNOWLEDGEMENTS</title>
<p>SE is a Wellcome Trust Senior Investigator (grant number WT098395/Z/12/Z). SEF has a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number: 105636/Z/14/Z). The authors thank Rebecca Ward (University of Exeter, Exeter, UK) for her technical assistance.</p>
</ack>
<ref-list content-type="cited-references" id="cen13841-bibl-0001">
<title>REFERENCES</title>
<ref id="cen13841-bib-0001">
<label>1</label>
<mixed-citation id="cen13841-cit-0001" publication-type="journal">
<string-name>
<surname>Maiorana</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dionisi‐Vici</surname>
<given-names>C</given-names>
</string-name>. <article-title>Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties</article-title>. <source xml:lang="en"/>J Inherit Metab Dis. <year>2017</year>;<volume>40</volume>:<fpage>531</fpage>‐<lpage>542</lpage>.<pub-id pub-id-type="pmid">28656511</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0002">
<label>2</label>
<mixed-citation id="cen13841-cit-0002" publication-type="journal">
<string-name>
<surname>Barthlen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Mohnike</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Mohnike</surname>
<given-names>K</given-names>
</string-name>. <article-title>Techniques in pediatric surgery: congenital hyperinsulinism</article-title>. <source xml:lang="en"/>Horm Res Paediatr. <year>2010</year>;<volume>74</volume>:<fpage>438</fpage>‐<lpage>443</lpage>.<pub-id pub-id-type="pmid">21160200</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0003">
<label>3</label>
<mixed-citation id="cen13841-cit-0003" publication-type="journal">
<string-name>
<surname>Kapoor</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Flanagan</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Arya</surname>
<given-names>VB</given-names>
</string-name>, <string-name>
<surname>Shield</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Ellard</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hussain</surname>
<given-names>K</given-names>
</string-name>. <article-title>Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism</article-title>. <source xml:lang="en"/>Eur J Endocrinol. <year>2013</year>;<volume>168</volume>:<fpage>557</fpage>‐<lpage>564</lpage>.<pub-id pub-id-type="pmid">23345197</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0004">
<label>4</label>
<mixed-citation id="cen13841-cit-0004" publication-type="journal">
<string-name>
<surname>Munns</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Batch</surname>
<given-names>J</given-names>
</string-name>. <article-title>Hyperinsulinism and Beckwith‐Wiedemann syndrome</article-title>. <source xml:lang="en"/>Arch Dis Child Fetal Neonatal Ed. <year>2001</year>;<volume>84</volume>:<fpage>F67</fpage>‐<lpage>F69</lpage>.<pub-id pub-id-type="pmid">11124932</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0005">
<label>5</label>
<mixed-citation id="cen13841-cit-0005" publication-type="journal">
<string-name>
<surname>Baujat</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rossignol</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Paradoxical NSD1 mutations in Beckwith‐Wiedemann syndrome and 11p15 anomalies in Sotos syndrome</article-title>. <source xml:lang="en"/>Am J Hum Genet. <year>2004</year>;<volume>74</volume>:<fpage>715</fpage>‐<lpage>720</lpage>.<pub-id pub-id-type="pmid">14997421</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0006">
<label>6</label>
<mixed-citation id="cen13841-cit-0006" publication-type="journal">
<string-name>
<surname>Gole</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chuk</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Coman</surname>
<given-names>D</given-names>
</string-name>. <article-title>Persistent hyperinsulinism in Kabuki syndrome 2: case report and literature review</article-title>. <source xml:lang="en"/>Clin Pract. <year>2016</year>;<volume>6</volume>:<fpage>848</fpage>.<pub-id pub-id-type="pmid">27777708</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0007">
<label>7</label>
<mixed-citation id="cen13841-cit-0007" publication-type="journal">
<string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Eklund</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Freeze</surname>
<given-names>HH</given-names>
</string-name>. <article-title>Congenital disorder of glycosylation Id presenting with hyperinsulinemic hypoglycemia and islet cell hyperplasia</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2005</year>;<volume>90</volume>:<fpage>4371</fpage>‐<lpage>4375</lpage>.<pub-id pub-id-type="pmid">15840742</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0008">
<label>8</label>
<mixed-citation id="cen13841-cit-0008" publication-type="journal">
<string-name>
<surname>Tegtmeyer</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Rust</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>van Scherpenzeel</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Multiple phenotypes in phosphoglucomutase 1 deficiency</article-title>. <source xml:lang="en"/>N Engl J Med. <year>2014</year>;<volume>370</volume>:<fpage>533</fpage>‐<lpage>542</lpage>.<pub-id pub-id-type="pmid">24499211</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0009">
<label>9</label>
<mixed-citation id="cen13841-cit-0009" publication-type="journal">
<string-name>
<surname>Cabezas</surname>
<given-names>OR</given-names>
</string-name>, <string-name>
<surname>Flanagan</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Stanescu</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2</article-title>. <source xml:lang="en"/>J Am Soc Nephrol. <year>2017</year>;<volume>28</volume>:<fpage>2529</fpage>‐<lpage>2539</lpage>.<pub-id pub-id-type="pmid">28373276</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0010">
<label>10</label>
<mixed-citation id="cen13841-cit-0010" publication-type="journal">
<string-name>
<surname>Alkhayyat</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Christesen</surname>
<given-names>ΗB</given-names>
</string-name>, <string-name>
<surname>Steer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Stewart</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Brusgaard</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hussain</surname>
<given-names>K</given-names>
</string-name>. <article-title>Mosaic turner syndrome and hyperinsulinaemic hypoglycaemia</article-title>. <source xml:lang="en"/>J Pediatr Endocrinol Metab. <year>2006</year>;<volume>19</volume>:<fpage>1451</fpage>‐<lpage>1457</lpage>.<pub-id pub-id-type="pmid">17252699</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0011">
<label>11</label>
<mixed-citation id="cen13841-cit-0011" publication-type="journal">
<string-name>
<surname>Ellard</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lango Allen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>De Franco</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Improved genetic testing for monogenic diabetes using targeted next‐generation sequencing</article-title>. <source xml:lang="en"/>Diabetologia. <year>2013</year>;<volume>56</volume>:<fpage>1958</fpage>‐<lpage>1963</lpage>.<pub-id pub-id-type="pmid">23771172</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0012">
<label>12</label>
<mixed-citation id="cen13841-cit-0012" publication-type="journal">
<string-name>
<surname>González‐Barroso</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Giurgea</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bouillaud</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion</article-title>. <source xml:lang="en"/>PLoS One. <year>2008</year>;<volume>3</volume>:<fpage>e3850</fpage>.<pub-id pub-id-type="pmid">19065272</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0013">
<label>13</label>
<mixed-citation id="cen13841-cit-0013" publication-type="journal">
<string-name>
<surname>Laver</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Weedon</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Caswell</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hussain</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ellard</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Flanagan</surname>
<given-names>SE</given-names>
</string-name>. <article-title>Analysis of large‐scale sequencing cohorts does not support the role of variants in UCP2 as a cause of hyperinsulinaemic hypoglycaemia</article-title>. <source xml:lang="en"/>Hum Mutat. <year>2017</year>;<volume>38</volume>:<fpage>1442</fpage>‐<lpage>1444</lpage>.<pub-id pub-id-type="pmid">28681398</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0014">
<label>14</label>
<mixed-citation id="cen13841-cit-0014" publication-type="journal">
<string-name>
<surname>Pinney</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Ganapathy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bradfield</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Dominant form of congenital hyperinsulinism maps to HK1 region on 10q</article-title>. <source xml:lang="en"/>Horm Res Paediatr. <year>2013</year>;<volume>80</volume>:<fpage>18</fpage>‐<lpage>27</lpage>.<pub-id pub-id-type="pmid">23859901</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0015">
<label>15</label>
<mixed-citation id="cen13841-cit-0015" publication-type="journal">
<string-name>
<surname>Köhler</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vasilevsky</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Engelstad</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>The human phenotype ontology in 2017</article-title>. <source xml:lang="en"/>Nucleic Acids Res. <year>2017</year>;<volume>45</volume>:<fpage>D865</fpage>‐<lpage>D876</lpage>.<pub-id pub-id-type="pmid">27899602</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0016">
<label>16</label>
<mixed-citation id="cen13841-cit-0016" publication-type="journal">
<string-name>
<surname>Van der Auwera</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Carneiro</surname>
<given-names>MO</given-names>
</string-name>, <string-name>
<surname>Hartl</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>From FastQ data to high‐confidence variant calls: the genome analysis toolkit best practices pipeline</article-title>. <source xml:lang="en"/>Curr Protoc Bioinformatics. <year>2002</year>;<volume>43</volume>:<fpage>11.10.1</fpage>‐<lpage>11.10.33</lpage>.</mixed-citation>
</ref>
<ref id="cen13841-bib-0017">
<label>17</label>
<mixed-citation id="cen13841-cit-0017" publication-type="miscellaneous">
<string-name>
<surname>Wakeling</surname>
<given-names>MN</given-names>
</string-name>. <article-title>SavvySuite</article-title>. <ext-link ext-link-type="uri" xlink:href="https://github.com/rdemolgen/SavvySuite">https://github.com/rdemolgen/SavvySuite</ext-link>. Accessed March 13, 2018.</mixed-citation>
</ref>
<ref id="cen13841-bib-0018">
<label>18</label>
<mixed-citation id="cen13841-cit-0018" publication-type="journal">
<string-name>
<surname>Glaser</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Thornton</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Otonkoski</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Junien</surname>
<given-names>C</given-names>
</string-name>. <article-title>Genetics of neonatal hyperinsulinism</article-title>. <source xml:lang="en"/>Arch Dis Child Fetal Neonatal Ed. <year>2000</year>;<volume>82</volume>:<fpage>F79</fpage>‐<lpage>F86</lpage>.<pub-id pub-id-type="pmid">10685979</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0019">
<label>19</label>
<mixed-citation id="cen13841-cit-0019" publication-type="journal">
<string-name>
<surname>Lek</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Minikel</surname>
<given-names>EV</given-names>
</string-name>, et al. <article-title>Analysis of protein‐coding genetic variation in 60,706 humans</article-title>. <source xml:lang="en"/>Nature. <year>2016</year>;<volume>536</volume>:<fpage>285</fpage>‐<lpage>291</lpage>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0020">
<label>20</label>
<mixed-citation id="cen13841-cit-0020" publication-type="journal">
<string-name>
<surname>Richards</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aziz</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bale</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source xml:lang="en"/>Genet Med. <year>2015</year>;<volume>17</volume>:<fpage>405</fpage>‐<lpage>423</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0021">
<label>21</label>
<mixed-citation id="cen13841-cit-0021" publication-type="journal">
<string-name>
<surname>Yap</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>AEK</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals</article-title>. <source xml:lang="en"/>Genet Med. <year>2018</year>; <pub-id pub-id-type="doi">10.1038/s41436-018-0013-9</pub-id> [Epub ahead of print].</mixed-citation>
</ref>
<ref id="cen13841-bib-0022">
<label>22</label>
<mixed-citation id="cen13841-cit-0022" publication-type="journal">
<string-name>
<surname>Landrum</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Benson</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>ClinVar: improving access to variant interpretations and supporting evidence</article-title>. <source xml:lang="en"/>Nucleic Acids Res. <year>2018</year>;<volume>46</volume>:<fpage>D1062</fpage>‐<lpage>D1067</lpage>.<pub-id pub-id-type="pmid">29165669</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0023">
<label>23</label>
<mixed-citation id="cen13841-cit-0023" publication-type="journal">
<string-name>
<surname>Staufner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lindner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dionisi‐Vici</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options</article-title>. <source xml:lang="en"/>J Inherit Metab Dis. <year>2016</year>;<volume>39</volume>:<fpage>273</fpage>‐<lpage>283</lpage>.<pub-id pub-id-type="pmid">26642971</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0024">
<label>24</label>
<mixed-citation id="cen13841-cit-0024" publication-type="journal">
<string-name>
<surname>Splawski</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Timothy</surname>
<given-names>KW</given-names>
</string-name>, <string-name>
<surname>Sharpe</surname>
<given-names>LM</given-names>
</string-name>, et al. <article-title>CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</article-title>. <source xml:lang="en"/>Cell. <year>2004</year>;<volume>119</volume>:<fpage>19</fpage>‐<lpage>31</lpage>.<pub-id pub-id-type="pmid">15454078</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0025">
<label>25</label>
<mixed-citation id="cen13841-cit-0025" publication-type="journal">
<string-name>
<surname>Flanagan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vairo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia</article-title>. <source xml:lang="en"/>Pediatr Diabetes. <year>2017</year>;<volume>18</volume>:<fpage>320</fpage>‐<lpage>323</lpage>.<pub-id pub-id-type="pmid">28318089</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0026">
<label>26</label>
<mixed-citation id="cen13841-cit-0026" publication-type="journal">
<string-name>
<surname>Henneveld</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>van Lingen</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Hamel</surname>
<given-names>BCJ</given-names>
</string-name>, <string-name>
<surname>Stolte‐Dijkstra</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>van Essen</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Perlman syndrome: four additional cases and review</article-title>. <source xml:lang="en"/>Am J Med Genet. <year>1999</year>;<volume>86</volume>:<fpage>439</fpage>‐<lpage>446</lpage>.<pub-id pub-id-type="pmid">10508986</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0027">
<label>27</label>
<mixed-citation id="cen13841-cit-0027" publication-type="journal">
<string-name>
<surname>Baumann</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Preece</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Green</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kelly</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>McKiernan</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>Hyperinsulinism in tyrosinaemia type I</article-title>. <source xml:lang="en"/>J Inherit Metab Dis. <year>2005</year>;<volume>28</volume>:<fpage>131</fpage>‐<lpage>135</lpage>.<pub-id pub-id-type="pmid">15877201</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0028">
<label>28</label>
<mixed-citation id="cen13841-cit-0028" publication-type="journal">
<string-name>
<surname>Terespolsky</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Farrell</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Siegel‐Bartelt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Weksberg</surname>
<given-names>R</given-names>
</string-name>. <article-title>Infantile lethal variant of Simpson‐Golabi‐Behmel syndrome associated with hydrops fetalis</article-title>. <source xml:lang="en"/>Am J Med Genet. <year>1995</year>;<volume>59</volume>:<fpage>329</fpage>‐<lpage>333</lpage>.<pub-id pub-id-type="pmid">8599356</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0029">
<label>29</label>
<mixed-citation id="cen13841-cit-0029" publication-type="journal">
<string-name>
<surname>Sheffield</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Yip</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ruchelli</surname>
<given-names>ED</given-names>
</string-name>, et al. <article-title>Fatal congenital hypertrophic cardiomyopathy and a pancreatic nodule morphologically identical to focal lesion of congenital hyperinsulinism in an infant with costello syndrome: case report and review of the literature</article-title>. <source xml:lang="en"/>Pediatr Dev Pathol. <year>2015</year>;<volume>18</volume>:<fpage>237</fpage>‐<lpage>244</lpage>.<pub-id pub-id-type="pmid">25668678</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0030">
<label>30</label>
<mixed-citation id="cen13841-cit-0030" publication-type="journal">
<string-name>
<surname>Højlund</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lajer</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>A novel syndrome of autosomal‐dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene</article-title>. <source xml:lang="en"/>Diabetes. <year>2004</year>;<volume>53</volume>:<fpage>1592</fpage>‐<lpage>1598</lpage>.<pub-id pub-id-type="pmid">15161766</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0031">
<label>31</label>
<mixed-citation id="cen13841-cit-0031" publication-type="journal">
<string-name>
<surname>Deeb</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Al Amoodi</surname>
<given-names>AA</given-names>
</string-name>. <article-title>A novel homozygous mutation in the mannose phosphate isomerase gene causing congenital disorder of glycation and hyperinsulinemic hypoglycemia in an infant</article-title>. <source xml:lang="en"/>Clin Case Rep. <year>2018</year>;<volume>6</volume>:<fpage>479</fpage>‐<lpage>483</lpage>.<pub-id pub-id-type="pmid">29531722</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0032">
<label>32</label>
<mixed-citation id="cen13841-cit-0032" publication-type="journal">
<string-name>
<surname>Hennewig</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Hadzik</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Vogel</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Congenital central hypoventilation syndrome with hyperinsulinism in a preterm infant</article-title>. <source xml:lang="en"/>J Hum Genet. <year>2008</year>;<volume>53</volume>:<fpage>573</fpage>.<pub-id pub-id-type="pmid">18340402</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0033">
<label>33</label>
<mixed-citation id="cen13841-cit-0033" publication-type="journal">
<string-name>
<surname>Böhles</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sewell</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Gebhardt</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Reinecke‐Lüthge</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Klöppel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Marquardt</surname>
<given-names>T</given-names>
</string-name>. <article-title>Hyperinsulinaemic hypoglycaemia—Leading symptom in a patient with congenital disorder of glycosylation Ia (phosphomannomutase deficiency)</article-title>. <source xml:lang="en"/>J Inherit Metab Dis. <year>2001</year>;<volume>24</volume>:<fpage>858</fpage>‐<lpage>862</lpage>.<pub-id pub-id-type="pmid">11916319</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0034">
<label>34</label>
<mixed-citation id="cen13841-cit-0034" publication-type="journal">
<string-name>
<surname>Gillis</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Krishnamohan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yaacov</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shaag</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jackman</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Elpeleg</surname>
<given-names>O</given-names>
</string-name>. <article-title>TRMT10A dysfunction is associated with abnormalities in glucose homeostasis, short stature and microcephaly</article-title>. <source xml:lang="en"/>J Med Genet. <year>2014</year>;<volume>51</volume>:<fpage>581</fpage>‐<lpage>586</lpage>.<pub-id pub-id-type="pmid">25053765</pub-id></mixed-citation>
</ref>
<ref id="cen13841-bib-0035">
<label>35</label>
<mixed-citation id="cen13841-cit-0035" publication-type="journal">
<string-name>
<surname>Smith</surname>
<given-names>VS</given-names>
</string-name>, <string-name>
<surname>Giacoia</surname>
<given-names>GP</given-names>
</string-name>. <article-title>Hyperinsulinaemic hypoglycaemia in an infant with mosaic trisomy 13</article-title>. <source xml:lang="en"/>J Med Genet. <year>1985</year>;<volume>22</volume>:<fpage>228</fpage>‐<lpage>230</lpage>.<pub-id pub-id-type="pmid">3892006</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>